The nature of the heparin lipemia-clearing reaction involves the activation of an enzyme, lipoprotein lipase, which splits the triglycerides of chylomicra and low-density lipoproteins. This activity has been demonstrated in plasma in vitro and in vivo, both after the injection of heparin and endogenously, and, at least in relation to postalimentary lipemia, apparently takes place within the bloodstream or at the capillary wall. The free fatty acids released after triglyceride lipolysis are bound to albumin and rapidly transported to the tissues. The distribution of the other triglyceride component, glycerol, has not been thoroughly investigated. There is much indirect evidence that heparin mobilizes the lipolytic enzyme (apparently present in the capillary wall), stabilizes its activity, and effects its rapid attachment to the chylomicron or lipoprotein substrate.
The heparin lipemia-clearing reaction thus circumvents the hitherto perplexing problem of the barrier that the capillary wall *Heparin levels in units/100 ml., 1 mg. = 100 units. Statistical analysis of the data showed a definitely significant (p<.01) negative correlation between heparin on the one hand and serum cholesterol and Sf 12-400 lipoproteins on the other in males.
In females the correlation between heparin and cholesterol was negative but fell short of the 5 per cent level of significance. The correlation between heparin and Sf 12-400 lipoproteins was negative and statistically definitely significant (p<.01). The correlation with the Sf 0-12 lipoproteins was also negative and probably significant (p<.05).
These results afford substantial evidence that a relative deficiency of circulating heparin is one of the important causative factors leading to elevated levels of serum lipid.
